The reality check up front: "best" here means best-studied, not proven and approved
Miss that distinction and you could be injecting twice your intended dose, or half of it, without ever knowing
The main concerns are local injection reactions, infection risk if sterility is breached, and misuse (e.g
M., Sanders, L., Rosenstock, J., Altman, M
scar tissue formation at the injury site Anti-inflammatory down-regulates NF-B signaling, one of the key inflammatory pathways active in disc herniations Works in synergy with BPC-157 while BPC-157 creates the growth signals, TB-500 provides the cellular migration framework to execute the repair Protocol: Loading phase: 2.5mg5mg/week subcutaneous injection for 46 weeks Maintenance: 1.252.5mg/week ongoing Frequency: Single weekly injection or split into two 1.25mg injections across the week (both approaches work) The Synergy: Why Run Both Together BPC-157 and TB-500 work through different but complementary mechanisms